Abiopharma

TEMPUS AI, INC. (TEM)

Symbol	TEM
Name	TEMPUS AI, INC.
Sector	TECHNOLOGY
Region	North America
Industry	Computer Software: Programming, Data Processing
Address	600 WEST CHICAGO AVENUE,SUITE 510, CHICAGO, Illinois, 60654, United States
Telephone	+1 800 - 976-5448
Fax	—
Email	—
Website	https://www.tempus.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001717115
Description	Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies. Additional info from NASDAQ: Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies.

2026-09-04 12:30

Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

2026-09-03 20:05

Epstein David R 🔴 sold 250 shares of Tempus AI, Inc. (TEM) at $65.55 Transaction Date: Sep 01, 2026 | Filing ID: 000012

2026-09-01 20:52

📋 JENNIFER DOUDNA (Director) plans to sell 676 shares of TEMPUS AI INC (at $63.05 each, total $43K) Filed: Sep 01, 2026 | ID: 008959

2026-09-01 20:42

📋 VANESSA KUBO (Officer) plans to sell 31K shares of Tempus AI, Inc. (at $63.05 each, total $1.9M) Filed: Sep 01, 2026 | ID: 008940

2026-09-01 20:15

West Nadja 🔴 sold 3.0K shares of Tempus AI, Inc. (TEM) at $69.00 Transaction Date: Aug 28, 2026 | Filing ID: 000006

2026-08-31 17:35

New Form S-4 - Tempus AI, Inc. Filed: 2026-08-31 AccNo: 0001193125-26-376895 Size: 3 MB

2026-08-28 00:28

LEFKOFSKY ERIC P 🔴 sold 11.8K shares of Tempus AI, Inc. (TEM) at $70.58 Transaction Date: Aug 25, 2026 | Filing ID: 000036

2026-08-28 00:27

LEFKOFSKY ERIC P 🔴 sold 238.2K shares of Tempus AI, Inc. (TEM) at $70.58 ($16.3M) Transaction Date: Aug 25, 2026 | Filing ID: 000034

2026-08-25 20:57

📋 Eric Lefkofsky (Officer) plans to sell 250K shares of Tempus AI, Inc. (at $66.17 each, total $16.5M) Filed: Aug 25, 2026 | ID: 000880

2026-08-25 20:15

Schoenherr Thomas Edward 🟢 acquired 2.7K shares of Tempus AI, Inc. (TEM) at $70.00 Transaction Date: Aug 21, 2026 | Filing ID: 000016